[go: up one dir, main page]

WO2001051072A3 - Agent antiparasitaire - Google Patents

Agent antiparasitaire Download PDF

Info

Publication number
WO2001051072A3
WO2001051072A3 PCT/GB2001/000147 GB0100147W WO0151072A3 WO 2001051072 A3 WO2001051072 A3 WO 2001051072A3 GB 0100147 W GB0100147 W GB 0100147W WO 0151072 A3 WO0151072 A3 WO 0151072A3
Authority
WO
WIPO (PCT)
Prior art keywords
antiparasitic agent
methods
intraerythrocytic
haptoglobin
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2001/000147
Other languages
English (en)
Other versions
WO2001051072A2 (fr
Inventor
Karen Day
Heather Imrie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to AU28626/01A priority Critical patent/AU2862601A/en
Publication of WO2001051072A2 publication Critical patent/WO2001051072A2/fr
Publication of WO2001051072A3 publication Critical patent/WO2001051072A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des méthodes de traitement d'états associés à la présence d'un protozoaire parasitaire intraérythrocytique dans un organisme hôte ainsi que des médicaments à utiliser dans des telles méthodes. Ces médicaments renferment une protéine liée à l'haptoglobine en tant que principe actif.
PCT/GB2001/000147 2000-01-14 2001-01-12 Agent antiparasitaire Ceased WO2001051072A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU28626/01A AU2862601A (en) 2000-01-14 2001-01-12 Antiparasitic agent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0000901.9A GB0000901D0 (en) 2000-01-14 2000-01-14 Antiparasitic agent
GB0000901.9 2000-01-14

Publications (2)

Publication Number Publication Date
WO2001051072A2 WO2001051072A2 (fr) 2001-07-19
WO2001051072A3 true WO2001051072A3 (fr) 2002-03-14

Family

ID=9883735

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/000147 Ceased WO2001051072A2 (fr) 2000-01-14 2001-01-12 Agent antiparasitaire

Country Status (3)

Country Link
AU (1) AU2862601A (fr)
GB (1) GB0000901D0 (fr)
WO (1) WO2001051072A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8475767B2 (en) 2009-04-27 2013-07-02 University Of George Research Foundation, Inc. Anti-trypanosomal peptides and uses thereof

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094704B2 (en) 2002-05-09 2006-08-22 Applied Materials, Inc. Method of plasma etching of high-K dielectric materials
US6902681B2 (en) 2002-06-26 2005-06-07 Applied Materials Inc Method for plasma etching of high-K dielectric materials
US6855643B2 (en) 2002-07-12 2005-02-15 Padmapani C. Nallan Method for fabricating a gate structure
US7368394B2 (en) 2006-02-27 2008-05-06 Applied Materials, Inc. Etch methods to form anisotropic features for high aspect ratio applications
US7846845B2 (en) 2006-10-26 2010-12-07 Applied Materials, Inc. Integrated method for removal of halogen residues from etched substrates in a processing system
US7655571B2 (en) 2006-10-26 2010-02-02 Applied Materials, Inc. Integrated method and apparatus for efficient removal of halogen residues from etched substrates
US7946759B2 (en) 2007-02-16 2011-05-24 Applied Materials, Inc. Substrate temperature measurement by infrared transmission
WO2009124941A2 (fr) * 2008-04-07 2009-10-15 Aarhus Universitet Composés trypanocides ciblant l’intérieur des trypanosomes
US8845816B2 (en) 2011-03-01 2014-09-30 Applied Materials, Inc. Method extending the service interval of a gas distribution plate
US8992689B2 (en) 2011-03-01 2015-03-31 Applied Materials, Inc. Method for removing halogen-containing residues from substrate
WO2020006179A1 (fr) * 2018-06-28 2020-01-02 Salaqua Diagnostics, Inc. Compositions et méthodes en relation avec une protéine associée à l'haptoglobine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008324A1 (fr) * 1989-01-17 1990-07-26 The Johns Hopkins University Haptoglobine apparentee au cancer (hpr)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008324A1 (fr) * 1989-01-17 1990-07-26 The Johns Hopkins University Haptoglobine apparentee au cancer (hpr)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MURANJAN M. ET AL.: "Characterization of the human serum trypanosome toxin, haptoglobine-related protein", J. BIOL. CHEM., vol. 273, no. 7, 13 February 1998 (1998-02-13), pages 3884 - 3887, XP002167805 *
RAPER J. ET AL.: "Characterization of novel trypanosome lytic factor from human serum", INFECT. IMMUN., vol. 67, no. 4, April 1999 (1999-04-01), pages 1910 - 1916, XP002167806 *
ROCKETT K.A. ET AL.: "Killing of blood-stage Plasmodium falcifarum by lipid peroxides from tumor necrosis serum.", INFECT. IMMUN., vol. 56, no. 12, December 1988 (1988-12-01), pages 3180 - 3183, XP002167807 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8475767B2 (en) 2009-04-27 2013-07-02 University Of George Research Foundation, Inc. Anti-trypanosomal peptides and uses thereof
US9079977B2 (en) 2009-04-27 2015-07-14 University Of Georgia Research Foundation, Inc. Anti-trypanosomal peptides and uses thereof

Also Published As

Publication number Publication date
WO2001051072A2 (fr) 2001-07-19
GB0000901D0 (en) 2000-03-08
AU2862601A (en) 2001-07-24

Similar Documents

Publication Publication Date Title
AU2002346379A1 (en) Dilation catheter assembly and related methods
AU2002326600A1 (en) Side-exit catheter and method for its use
AU2002241520A1 (en) Blood assessment of injury
AU2001296217A1 (en) Magnetically navigated pacing leads, and methods for delivering medical devices
AU2002357351A1 (en) Implantable medical device and method for manufacturing the same
WO2003015809A3 (fr) Peptides cationiques antimicrobiens et formulations associees
AU2002350967A1 (en) Medical electrode system and method
AU2002347910A1 (en) Methods and compositions for targeting proteins across the blood brain barrier
AU2001289308A1 (en) Targeted agents useful for diagnostic and therapeutic applications
MXPA03007690A (es) Prenda absorbente y metodo para proporcionar la misma.
WO2001051072A3 (fr) Agent antiparasitaire
AU2001256373A1 (en) Syringe and method for the use thereof
AU2002242904A1 (en) Skin treatment comprising alcohol spirit
WO2003063725A3 (fr) Procedes pour prevenir et traiter une infection a flavivirus chez des animaux
AU2002309083A1 (en) Method for identifying drugs for the treatment of type ii diabetes
WO2001089558A3 (fr) Preparations et techniques permettant de traiter des hypercoagulations
AU2002360696A1 (en) Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment for multiple sclerosis
IL158967A0 (en) Identifying parasitic fungi of the organism, and treatment thereof
WO2002066513A3 (fr) Fragments humains de lekti circulants hf7072, hf7638 et hf14448 ainsi que leur utilisation
WO2002024223A3 (fr) Prevention et traitement d'une infection streptococcique et staphylococcique
WO2001052654A3 (fr) Combinaison d'agents biologiques et chimiques de lutte contre les rongeurs
WO2003096877A3 (fr) Prevention et traitement d'infections streptococciques et staphylococciques
AU2001239523A1 (en) Blood transfusion method and device
AU2002304492A1 (en) Identifying parasitic fungi of the organism, and treatment thereof
MXPA01008957A (es) Procedimiento para la recuperacion de proteinas de sangre de cerdo y su conservacion.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP